- Price
Supplier Type
- Manufacturer
- Reagent
- contract manufacturer
- custom synthesis
- Trader
Supplier Region
- Telangana(14)
- AndhraPradesh(4)
- Maharashtra(31)
- Uttar Pradesh(2)
- Hyderabad(5)
- New Delhi(11)
- Gujarat(12)
- Haryana(5)
- Karnataka(3)
- Punjab(1)
- Ahmedabad(2)
- Madhya Pradesh(1)
- Tamil Nadu(4)
- Himachal Pradesh(2)
- Mumbai(4)
- Kerela(1)
- Vadodara(1)
- Andhra Pradesh(1)
- Delhi(1)
Purity
- VETRANAL?, analytical standard
- United States Pharmacopeia (USP) Reference Standard
- Tamoxifen is a potent synthetic anti-estrogenic agent.
- suitable for fluorescence, 98.0-102.0% (HPLC)
- solution, suitable for blocking, sterile
- solid
- recombinant, expressed in Pichia pastoris, suitable for cell culture
- purum, ≥97.0% (HPLC)
- purified immunoglobulin, buffered aqueous solution
- powder, contains NaCl as solubilizer
- powder, BioReagent, suitable for cell culture
- powder
- phyproof? Reference Substance
- pharmaceutical secondary standard, certified reference material
- Pharmaceutical Secondary Standard
- PESTANAL?, analytical standard
- mixture of endo/exo 95%
- mitochondrial hexokinase inhibitor
- Indole alkaloid that binds to tubulin, inhibiting formation of microtubules.
- IL-2, recombinant, expressed in HEK 293 cells, suitable for cell culture, endotoxin tested
- IL-2, recombinant, expressed in E. coli, lyophilized powder, suitable for cell culture
- Hybri-Max?, 50?×, γ-irradiated, lyophilized powder, BioXtra, suitable for hybridoma
- HCl 96%
- for synthesis
- European Pharmacopoeia (EP) Reference Standard
- DNA synthesis and methylation inhibitor
- crystalline
- CRS, European Pharmacopoeia (EP) Reference Standard
- clone 41AT858.235, IgG fraction of antiserum, buffered aqueous solution
- clone 1E7, purified immunoglobulin, buffered aqueous solution
- certified reference material, pharmaceutical secondary standard
- Certified Reference Material
- British Pharmacopoeia (BP) Reference Standard
- Antitumor and antileukemic agent isolated from the bark of the yew tree.
- analytical standard, for drug analysis
- analytical standard
- AldrichCPR
- A phenolic product found in both grape skins and wines.
- A cell-permeable powerful DNA topoisomerase I inhibitor.
- A cell-permeable DNA topoisomerase I inhibitor.
- 99+%
- 99.9%
- >99.0%(GC)
- ≥99.0% (TLC)
- ≥99.0% (sum of enantiomers, HPLC)
- 99%+
- ≥99% (HPLC)
- 99%
- 98.50%
- 98.0-102.0% (HPLC)
- 98.0-102.0%
- 98.0-102%
- >98.0%(T)(HPLC)
- >98.0%(N)
- >98.0%(HPLC)(qNMR)
- >98.0%(HPLC)(N)
- >98.0%(HPLC)
- >98.0%(GC)(T)
- >98.0%(GC)
- ≥98% (perchloric acid titration)
- ≥98% (HPLC), solid
- ≥98% (HPLC), powder
- ≥98% (HPLC)
- 98%
- >98%
- ≥98%
- ≥970?μg/mg (USP XXIV)
- >97.5% (Pt analysis)
- >97.0%(T)(HPLC)
- >97.0%(T)
- >97.0%(N)
- >97.0%(HPLC)(N)
- >97.0%(HPLC)
- ≥97% (HPLC)
- 97%
- 95-99%
- 95-99 %
- >95.0%(HPLC)
- ≥95% (HPLC)
- 95%
- ≥95%
- ≥90% (HPLC), powder
- ≥90% (HPLC)
- 90%
- 90 % Above
- >85.0%(HPLC)
- 10.0?mg/mL (12.5 mM Histidine Buffer), certified reference material, Cerilliant?
- 1?mg/mL in acetonitrile, certified reference material, ampule of 1?mL, Cerilliant?
- 1.5-2.0U/mg
- 1.0?mg/mL in methanol with 0.1N NaOH, ampule of 1?mL, certified reference material, Cerilliant?
- 0.2 μm filtered
- ~1.25?M HCl (T), for GC derivatization, LiChropur?
- &ge
Package
- 0the rest upon order
- 10μg
- 20μg
- 5x10μg
- 50μg
- 100μg
- 351μg
- 500μg
- 1mg
- 1.01mg
- 2Mg
- 2.5mg
- 4.96mg
- 5MG-F
- 5mg
- 7mg
- 10mg
- 5x2mg
- 15mg
- 10x2mg
- 20mg
- 25MG-F
- 40mg
- 60mg
- 70mg
- 75mg
- 80mg
- 110mg
- 120mg
- 130mg
- 150mg
- 300mg
- 5g,5g
- 0.25mL
- 1g,1g
- 350mg
- 10g,10g
- 25mg
- 50mg
- 55mg
- 100mg
- 125mg
- 200MG
- 250mg
- 400mg
- 1gm
- 25125kg and 1 MT
- 50010500 mg and 1.0 gm
- 151-5 gm
- 0.5g
- 500mg
- 1mL
- 1G
- 5gm
- 5G
- 10g
- 10gm
- 20mL
- 25gm
- 25g
- 50g
- 100mL
- 100gm
- 100g
- 250mL
- 500g
- 1kg
- 5kg
- 10kg
- 25kg
- 1Gms
- 1MT
- 1 kg
- 5 kg
- 5Gms
- 10 kg
- 10vials
- 15units
- 18%
- 25kgs
- 400μL
- 0.18
- Kg
- 50kgs
- 100μL
- 10000units
4-(4-Methylpiperazin-1-ylmethyl)-3-trifluoromethylaniline 694499-26-8
4-[(4-METHYLPIPERAZIN-1-YL) METHYL]-N-[4-METHYL-3-[(4-PYRIDIN-3-YLPYRIMIDIN-2-YL)AMINO]-PHENYL]-BENZAMIDE 152459-95-5
Erlotinib hydrochloride 183319-69-9